We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$6.58B
AUM Growth
-$16.9M
Cap. Flow
-$345M
Cap. Flow %
-5.24%
Top 10 Hldgs %
19.23%
Holding
670
New
207
Increased
92
Reduced
126
Closed
222

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$119M
2
ADI icon
Analog Devices
ADI
+$91.5M
3
PAYC icon
Paycom
PAYC
+$76.8M
4
PANW icon
Palo Alto Networks
PANW
+$71M
5
AZEK
The AZEK Co
AZEK
+$59.1M

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 14.97%
3 Industrials 11.6%
4 Consumer Discretionary 11.16%
5 Financials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
601
Zoetis
ZTS
$30.9B
-22,207
Closed -$3.04M
CPAY icon
602
Corpay
CPAY
$26.3B
-27,861
Closed -$7.01M
BWIN
603
Baldwin Insurance Group
BWIN
$2.79B
-264,402
Closed -$4.57M
GAP
604
The Gap Inc
GAP
$7.74B
-311,004
Closed -$3.92M
SGI
605
Somnigroup International
SGI
$13.6B
-253,392
Closed -$4.56M
NVRO
606
DELISTED
NEVRO CORP.
NVRO
-118,491
Closed -$14.2M
SYRS
607
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-8,613
Closed -$918K
NTBL
608
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
-2,381
Closed -$107K
CALT
609
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
-99,873
Closed -$2.32M
SILK
610
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-166,168
Closed -$6.96M
VBIV
611
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
-7,333
Closed -$682K
SWAV
612
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-42,970
Closed -$2.04M
FTCH
613
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-331,437
Closed -$5.72M
KLR
614
DELISTED
Kaleyra, Inc.
KLR
-99,861
Closed -$1.41M
DMS
615
DELISTED
Digital Media Solutions, Inc.
DMS
-1,917
Closed -$299K
BNGOW
616
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
-1,163,000
Closed -$593K
PDCE
617
DELISTED
PDC Energy, Inc.
PDCE
-20,810
Closed -$259K
ISEE
618
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-153,767
Closed -$784K
BLCM
619
CALL
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-200,000
Closed -$1.49M
FSTX
620
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-50,000
Closed -$294K
VIVE
621
CALL
DELISTED
VIVEVE MED INC
VIVE
-16,300
Closed -$92K
SPNE
622
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-126,285
Closed -$1.32M
PING
623
DELISTED
Ping Identity Holding Corp.
PING
-200,922
Closed -$6.45M
FMTX
624
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
-24,501
Closed -$1.14M
CTXS
625
DELISTED
Citrix Systems Inc
CTXS
-486,821
Closed -$72M

Similar funds

Alyeska Investment Group's Q3 2020 Portfolio in Review

As of Q3 2020, Alyeska Investment Group held 670 positions worth $6.58B, down 0.26% from $6.59B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alyeska Investment Group withdrew a net $345M in Q3 2020, closing 222 positions and reducing 126 holdings. Its most notable exit was Texas Instruments, an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Microsoft worth $119M.

  • Alyeska Investment Group's largest Q3 2020 buy was Microsoft: 568,147 shares worth $119M.
  • Alyeska Investment Group added most to Paycom in Q3 2020, an estimated $76.8M increase.
  • Alyeska Investment Group's biggest Q3 2020 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Alyeska Investment Group fully exited Texas Instruments in Q3 2020, selling an estimated $142M.
  • Alyeska Investment Group's ten largest holdings make up 19% of its $6.58B portfolio in Q3 2020.
  • Alyeska Investment Group opened 207 new positions and closed 222 in Q3 2020.
  • Alyeska Investment Group's portfolio value fell 0.26% quarter-over-quarter to $6.58B.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.